Mounjaro 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM2ZL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,732
Award facts
- Contract value 100% obligated
- $10,732.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10.7 thousand delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Mounjaro 10 mg/0.5 mL pens with an ultimate completion date of January 23, 2026. This delivery order is structured as a firm fixed-price contract with no set-aside designation, indicating full and open competition. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This award is a child order under AmerisourceBergen's parent company, Cencora, Inc., which operates the pharmaceutical distributor under the doing-business-as name AmerisourceBergen.
This delivery order falls under Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. Mounjaro, a diabetes medication, aligns with the extensive therapeutic domains covered under the parent IDC, which encompasses specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements through competitive awards and its established role as a prime pharmaceutical vendor to the Defense Logistics Agency support its selection for this delivery order serving military healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM2ZL?
SPE2DR26FM2ZL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FM2ZL worth?
The government has obligated $10,732 on SPE2DR26FM2ZL.
Is contract SPE2DR26FM2ZL an order under another contract?
Yes. SPE2DR26FM2ZL is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2ZL competed?
The extent of competition for SPE2DR26FM2ZL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award